Duhring Dermatology Case & Quality Improvement Conference
January 5, 2017
9:00 AM – 11:00 AM
PCAM & Smilow
Dr. Amanda Derwae
University of Pennsylvania
Philadelphia, PA
Target Audience
This program has been designed for physicians, fellows, residents, medical students, QI professionals, quality care, risk management, professional nurses, advanced practice nurses and researchersin dermatology.
Series Educational Objectives
After completing this activity, participants should be able to:
- Diagnose a patient with a rare or difficult skin condition
- Discuss the best treatments for rare dermatologic diseases using an interprofessional team approach
- Recognize and treat dermatosis in the dermatologic patient
- Reduce medical errors and unnecessary testing to improve quality of care and patient safety
Accreditation
Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses: Penn Medicine Nursing is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval # 124-3-H-15
Designation of Credit
Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 2 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Nurse participants will be awarded 2.0 contact hour.
PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2 Category 1 credits for completing this activity.
Approved for (PSRM) patient safety/risk management designation
Acknowledgement of Commercial Support* NONE
For more information, please contact
Maria Torres
215-537-3387
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, DNP, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee & Presenter Name
William James, MD / Veronica Richardson, MSN, CRNP, ANP-BCBrandi Eldridge / Mary Beth Forte / Maria Torres
Presenter Name
Oyinade Adenbigbe / John Barbieri / John O. Barton, MD / Mark A. Bechtel, MD / Bruce A. Brad, MDKatherine Brown, MD / Avrom Caplan / Filberto Cedano-Laurent / Aileen Chang / Juliana Choi
Emimlyu Chu, MD, PHD / Anna Cogen / Christine Cornejo / Danielle Dettoratius / Amanda Derwae
Amy Forrestel, md / Mary-Beth Forte / Zelma Chlesa Fuxench / Joel Gelfand, MD / Paul Hawn
Elizabeth Heller / Warren R. Heymann, MD / Sotonye Imadojemy, md / Carrie Kovarik, MD / Matthew LeBoeuf, md
Thomas Leung / Sarah E. Millar / Christopher Miller, MD / Mark Mochel / Badri Modi, MD
Ata Moshiri / Caroline Nelson / Jennifer Nguyen / Megan Noe / Lauren Orenstein, md
Douglas Pugliese, MD / Veronica Richardson, np / Todd Ridky, MD, PhD / Rudolf Roth, MD / Adam Rubin, MD
Robert Rudolph, MD / Michael Saruk, MD / Waqas Shaikh, md / Cory L. Simpson, MD, PhD / Joseph Sobanko, MD
Stephen Solotoff, MD / Natalie Spacarelli / John Stanley, md / Katherine Steele, md / Sasha Stephen, md
Jenna Streicher / Marie Uberti-Benz / Jennifer Villasenor-Park / Carmela Vittorio, MD / Joy Wan
Michelle Weir / Mackenzie Wehner, md / Xuegang Xu / Toby Frank Zachian, MD
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
Planning Committee & Presenter NameName of Commercial InterestRelationship
George Cotsarelis, MDAllergan, Johnson & JohnsonPI
MIsha Rosenbach, MDCelgeneAdvisory Board
Presenter NameName of Commercial InterestRelationship
Aimee Payne, MD, PhDTG Therapeutics & SyntimmuneConsultant
Jules LipoffSpringerRoyalties
PfizerPI
David J. Margolis, MDKarecisAdvisory Board
Clementia, Rengeron/Sanofi, Janssen, Stiefel/GSK, AstellasDSMB
Junko TakeshitaPfizerInvestigator
Victoria WerthMedimmune, GSK, IDera, Biogen, Xoma, Janssen, Kirin, ImmunotherapeuticsConsultant
Genentech, CelgeneConsultant -Clinical Trial
NovartisClinical Trial
Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
Disclosure of Unapproved Uses of Products
Presenter nameProductInvestigational and/or Off-label Use